COPAXONE Drug Patent Profile
✉ Email this page to a colleague
When do Copaxone patents expire, and when can generic versions of Copaxone launch?
Copaxone is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in COPAXONE is glatiramer acetate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the glatiramer acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Copaxone
A generic version of COPAXONE was approved as glatiramer acetate by MYLAN on October 3rd, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COPAXONE?
- What are the global sales for COPAXONE?
- What is Average Wholesale Price for COPAXONE?
Summary for COPAXONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Clinical Trials: | 52 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for COPAXONE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for COPAXONE |
What excipients (inactive ingredients) are in COPAXONE? | COPAXONE excipients list |
DailyMed Link: | COPAXONE at DailyMed |
![COPAXONE drug patent expirations Drug patent expirations by year for COPAXONE](/p/graph/s/t/COPAXONE-patent-expirations.png)
![Drug Prices for COPAXONE](/p/graph/drug-price/COPAXONE.png)
![Drug Sales Revenue Trends for COPAXONE](/p/graph/drug-sales-revenues/COPAXONE.png)
Recent Clinical Trials for COPAXONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Kansas Medical Center | Phase 1 |
Genzyme, a Sanofi Company | Phase 3 |
Teva Pharmaceutical Industries, Ltd. | Phase 4 |
Paragraph IV (Patent) Challenges for COPAXONE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
COPAXONE | Injection | glatiramer acetate | 40 mg/mL, 1 mL pre- filled syringe | 020622 | 2 | 2014-02-26 |
COPAXONE | Injection | glatiramer acetate | 20 mg/mL, 1mL pre- filled syringe | 020622 | 1 | 2007-12-27 |
US Patents and Regulatory Information for COPAXONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | COPAXONE | glatiramer acetate | FOR SOLUTION;SUBCUTANEOUS | 020622-001 | Dec 20, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms Usa | COPAXONE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 020622-002 | Feb 12, 2002 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Pharms Usa | COPAXONE | glatiramer acetate | INJECTABLE;SUBCUTANEOUS | 020622-003 | Jan 28, 2014 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COPAXONE
International Patents for COPAXONE
See the table below for patents covering COPAXONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2017132773 | 低頻度酢酸グラチラマー治療 (LOW FREQUENCY GLATIRAMER ACETATE THERAPY) | ⤷ Sign Up |
Portugal | 3199172 | ⤷ Sign Up | |
Argentina | 122567 | TERAPIA DE BAJA FRECUENCIA CON ACETATO DE GLATIRAMER | ⤷ Sign Up |
China | 1310673 | ⤷ Sign Up | |
Eurasian Patent Organization | 201990217 | ТЕРАПИЯ ГЛАТИРАМЕРОМ АЦЕТАТОМ С НИЗКОЙ КРАТНОСТЬЮ | ⤷ Sign Up |
Slovakia | 283699 | ⤷ Sign Up | |
Eurasian Patent Organization | 032283 | ТЕРАПИЯ ГЛАТИРАМЕРОМ АЦЕТАТОМ С НИЗКОЙ КРАТНОСТЬЮ (LOW FREQUENCY GLATIRAMER ACETATE THERAPY) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for COPAXONE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0762888 | C300096 | Netherlands | ⤷ Sign Up | PRODUCT NAME: GLATIRAMEER, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET ACETAAT; NAT. REGISTRATION NO/DATE: RVG 26748 20010927: FIRST REGISTRATION: GB PL 10921/0019 20000809 |
0762888 | C300251 | Netherlands | ⤷ Sign Up | PRODUCT NAME: GLATIRAMEER, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET ACETAAT; NATL. REGISTRATION NO/DATE: RVG 26748 20010927; FIRST REGISTRATION: GB PL 10921/0019 20000809 |
0762888 | 90987 | Luxembourg | ⤷ Sign Up | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |